FDA Drug Application (013621) for PERTOFRANE by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number013621
Product Number001
FormCAPSULE;ORAL
Dosage25MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePERTOFRANE
Active IngredientDESIPRAMINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient DESIPRAMINE HYDROCHLORIDE3


Back to FDA Applications sponsored by SANOFI AVENTIS US